IceCure Medical Ltd. Ordinary Shares

Go to IceCure Medical Ltd. Ordinary Shares Website

$0.90

0.01 (1.12%)
Live
Previous Close

$0.89

Day Range

$0.87 - $0.9101

Previous Day Range

$0.88 - $0.92

Market Cap

$54.0 million USD

Day Vol.

147666

Previous Day Vol.

792403

Currency

USD

Primary Exchange

Nasdaq

Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation tech...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

IceCure Medical will release its first half 2025 financial and operational results on August 13, 2025, with a conference call scheduled for 11:00 am EDT to discuss the results and corporate developments.

Related tickers: ICCM.

Read Full Article

IceCure Medical reported stable Q1 2025 results, with revenue and gross margin slightly down year-over-year. The company submitted a post-market study plan to the FDA for its ProSense cryoablation system, a key step towards potential marketing authorization for early-stage breast cancer treatment in women aged 70 and older. IceCure is preparing for a U.S. commercial launch upon FDA approval and is also pursuing regulatory filings in Japan and Israel.

Related tickers: ICCM.

Read Full Article
Trending Tickers

Please sign in to view